Stock Scorer

iBio, Inc. (IBIO)

iBio, Inc. reported revenue of 0 USD for the quarter ending 31 March 2026.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q1 '26 · ending 31 March 2026 0 —
Gross Profit Q2 '22 · ending 30 June 2022 46K -84.9%
Operating Income Q1 '26 · ending 31 March 2026 -8.4M —
Net Income Q2 '26 · ending 30 June 2026 -10.4M —
Cost of Revenue Q2 '22 · ending 30 June 2022 15K -92.0%
Operating Cash Flow Q1 '26 · ending 31 March 2026 -6.1M —
Free Cash Flow Q1 '26 · ending 31 March 2026 -6.1M —
Shares Outstanding Q1 '26 · ending 31 March 2026 119.6M +1209.7%
EPS Q1 '26 · ending 31 March 2026 -0.57 -126.6%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-06-30 400K-18.6M-18.4M-15.3M
20242024-06-30 225K-16.6M-24.9M-18.8M
20232023-06-30 0-29.3M-65M-36.2M
20222022-06-30 1.9M-29.7M-50.3M-44.8M
20212021-06-30 2.4M-31.1M-23.2M-35M
20202020-06-30 1.6M-14M-16.4M-14.4M
20192019-06-30 2M-15.8M-17.6M-14.9M
20182018-06-30 444K-14.2M-16.1M-14.4M
20172017-06-30 394K-14.3M-14.5M-14.5M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q3 '262026-03-310
Q2 '262025-12-310
Q1 '262025-09-30100K
Q4 '252025-06-30200K
Q3 '252025-03-310
Q2 '252024-12-31200K
Q1 '252024-09-300
Q4 '242024-06-30175K
Q3 '242024-03-310
Q2 '242023-12-310
Q1 '242023-09-3050K
Q4 '232023-06-300
Q3 '232023-03-310
Q2 '232022-12-310
Q1 '232022-09-300
Q4 '222022-06-300
Q3 '222022-03-311.8M
Q2 '222021-12-310
Q1 '222021-09-3084K
Q4 '212021-06-30491K

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '222022-06-3046K
Q3 '222022-03-311.9M
Q2 '222021-12-3155K
Q1 '222021-09-30171K
Q4 '212021-06-30304K
Q3 '212021-03-31272K
Q2 '212020-12-31494K
Q1 '212020-09-30303K
Q4 '202020-06-30821K
Q3 '202020-03-3110K

Operating Income Quarterly

PeriodEndingOperating Income
Q3 '262026-03-31-8.4M
Q2 '262025-12-31-9.4M
Q1 '262025-09-30-6M
Q4 '252025-06-30-5.2M
Q3 '252025-03-31-4.9M
Q2 '252024-12-31-4.4M
Q1 '252024-09-30-4.1M
Q4 '242024-06-30-3.4M
Q3 '242024-03-31-3.6M
Q2 '242023-12-31-4.5M
Q1 '242023-09-30-5.1M
Q4 '232023-06-30-5M
Q3 '232023-03-31-6.2M
Q2 '232022-12-31-10.6M
Q1 '232022-09-30-7.6M
Q4 '222022-06-30-10.5M
Q3 '222022-03-31-6.8M
Q2 '222021-12-31-7.2M
Q1 '222021-09-30-5.2M
Q4 '212021-06-30-9.4M

Net Income Quarterly

PeriodEndingNet Income
Q4 '262026-06-30-10.4M
Q3 '262026-03-31-7.7M
Q2 '262025-12-31-9M
Q1 '262025-09-30-5.7M
Q4 '252025-06-30-5.2M
Q3 '252025-03-31-4.9M
Q2 '252024-12-31-4.4M
Q1 '252024-09-30-4M
Q4 '242024-06-30-7.8M
Q3 '242024-03-31-3.2M
Q2 '242023-12-31-8.2M
Q1 '242023-09-30-5.7M
Q4 '232023-06-30-6M
Q3 '232023-03-31-7.3M
Q2 '232022-12-31-33.6M
Q1 '232022-09-30-18.1M
Q4 '222022-06-30-17.1M
Q3 '222022-03-31-12.4M
Q2 '222021-12-31-11.9M
Q1 '222021-09-30-8.9M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q4 '222022-06-3015K
Q3 '222022-03-3148K
Q2 '222021-12-31113K
Q1 '222021-09-3040K
Q4 '212021-06-30187K
Q3 '212021-03-31493K
Q2 '212020-12-31211K
Q1 '212020-09-30107K
Q4 '202020-06-30299K
Q3 '202020-03-3186K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q3 '262026-03-31-6.1M
Q2 '262025-12-31-5.2M
Q1 '262025-09-30-5.7M
Q4 '252025-06-30-4.6M
Q3 '252025-03-31-3.1M
Q2 '252024-12-31-3.9M
Q1 '252024-09-30-3.7M
Q4 '242024-06-30-4.9M
Q3 '242024-03-31-3.7M
Q2 '242023-12-31-4.7M
Q1 '242023-09-30-5.3M
Q4 '232023-06-30-5M
Q3 '232023-03-31-3.9M
Q2 '232022-12-31-7.6M
Q1 '232022-09-30-14M
Q4 '222022-06-30-11.5M
Q3 '222022-03-31-5.9M
Q2 '222021-12-31-10.7M
Q1 '222021-09-30-9.3M
Q4 '212021-06-30-7.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q3 '262026-03-31-6.1M
Q2 '262025-12-31-5.8M
Q1 '262025-09-30-5.7M
Q4 '252025-06-30-4.6M
Q3 '252025-03-31-3.1M
Q2 '252024-12-31-3.9M
Q1 '252024-09-30-3.7M
Q4 '242024-06-30-5.1M
Q3 '242024-03-31-3.7M
Q4 '232023-06-30-5.5M
Q3 '232023-03-31-4.1M
Q2 '232022-12-31-10.6M
Q1 '232022-09-30-16.4M
Q4 '222022-06-30-14.9M
Q3 '222022-03-31-6.6M
Q2 '222021-12-31-12.8M
Q1 '222021-09-30-10.5M
Q4 '212021-06-30-9.7M
Q3 '212021-03-31-8.3M
Q2 '212020-12-31-9.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q3 '262026-03-31119.6M
Q2 '262025-12-3199.1M
Q1 '262025-09-3053M
Q3 '252025-03-319.9M
Q2 '252024-12-319.1M
Q1 '252024-09-308.6M
Q3 '242024-03-313.7M
Q2 '242023-12-311.9M
Q1 '242023-09-301.2M
Q3 '232023-03-31659K
Q2 '232022-12-31490K
Q1 '232022-09-308.8M
Q3 '222022-03-318.7M
Q2 '222021-12-318.7M
Q1 '222021-09-308.7M
Q3 '212021-03-31215.5M
Q2 '152014-12-3171M
Q1 '152014-09-3065.9M
Q2 '142013-12-3164M
Q1 '142013-09-3060.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q3 '262026-03-31-0.57
Q2 '262025-12-31-1.00
Q1 '262025-09-30-1.39
Q4 '252025-06-30-1.74
Q3 '252025-03-312.14
Q2 '252024-12-311.78
Q1 '252024-09-30-2.16
Q4 '242024-06-30-6.50
Q3 '242024-03-31-4.98
Q2 '242023-12-31-15.20
Q1 '242023-09-30-79.21
Q4 '232023-06-30-76.46
Q3 '232023-03-31-83.51
Q2 '232022-12-31-73.86
Q1 '232022-09-30-6.80
Q4 '222022-06-30-7.15
Q3 '222022-03-31-8.07
Q2 '222021-12-31-6.69
Q1 '222021-09-30-5.36
Q4 '212021-06-30-3.01